Supernus Pharmaceuticals (SUPN) Share-based Compensation (2011 - 2026)
Supernus Pharmaceuticals' Share-based Compensation was $8.64 million in Q2 2026, up 15.1% from $7.51 million a year earlier and up 1.9% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Share-based Compensation (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' Share-based Compensation was $34.6 million through Jun 30, 2026, up 12.0% year-over-year; for FY2025, it was $33.05 million, up 19.1% from FY2024.
- Share-based Compensation has now increased for three consecutive years, with a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $27.76 million in FY2024 (+3.7%), $26.76 million in FY2023 (+52.3%), $17.57 million in FY2022 (-1.9%) and $17.91 million in FY2021 (+8.1%).
- Quarterly Share-based Compensation has moved between $4.03 million (Q1 2022) and $9.65 million (Q4 2025) over five years.
- Compared with a year earlier, Share-based Compensation has increased for seven straight quarters, with growth averaging 14.4% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2023 (growth of 58.9%); the worst was Q2 2022 (a decline of 21.5%).
- Per Business Quant data, SUPN's Share-based Compensation in the three quarters before Q2 2026 was $8.48 million (Q1 2026), $9.65 million (Q4 2025) and $7.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | 8.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.64 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Dec 31, 2025 | 9.65 Mn |
| Sep 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.51 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 6.09 Mn |
| Mar 31, 2023 | 6.31 Mn |
| Dec 31, 2022 | 4.26 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 4.03 Mn |
API Access
Supernus Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();